FDA panel to consider loosening regulations for some peptides
Summary
A Food and Drug Administration (FDA) advisory panel is meeting to discuss whether compounding pharmacies should be allowed to make some unapproved peptides. These peptides are short protein pieces that some people want for uses like healing injuries, but they have not been fully tested or approved by the FDA.Key Facts
- Peptides are small chains of amino acids, naturally made by the body, and some approved peptides are used in medicines like insulin.
- There is growing interest in unapproved peptides sold online, often labeled for "research use only" without scientific proof of safety or benefits.
- The FDA panel will review seven unapproved peptides to decide if compounding pharmacies can make them with a doctor's prescription.
- Compounding pharmacies prepare medicines not widely made by drug companies, but production must be safe and controlled.
- Some popular peptides discussed include BPC-157, claimed to help with healing, though it has been tested on very few people.
- Experts warn that buying peptides online can be risky due to possible contamination or harmful substances.
- During the Biden administration, the FDA blocked many peptides from being compounded, citing safety concerns.
- Some officials believe there may be pressure on the FDA panel because a government official supports the use of these unapproved peptides.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
